Product Information
ERTAPENEM 1 GRAM VIAL is a generic product labeled by WG Critical Care, LLC, priced at $26.6295 per EA under NDC 44567082010. Its NADAC has been published 172 times since Jun 21, 2023.
FDA first approved this application on Apr 16, 2018. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/1
Manufacturer
WG Critical Care, LLCNDC
44567082010
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
ERTAPENEM SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208790FDA Approved
4/16/2018
TE Code
AP
On Market Since
1/7/2020
Pharmacological Classes
Price Statistics
The NADAC for ERTAPENEM 1 GRAM VIAL has been published 172 times since Jun 21, 2023, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.6295 per EA |
|---|---|
| All-time high | $46.9256 (Jul 10, 2024) |
| All-time low | $25.8742 (Jan 21, 2026) |
| 52-week high | $33.0269 |
| 52-week low | $25.8742 |
| Median price | $36.3239 |
| Average price | $36.6350 |
| Largest weekly change | -9.8% (Nov 19, 2025) |
| Weeks tracked | 172 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ertapenem market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
WG Critical Care, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ertapenem market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penem Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERTAPENEM 1 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ERTAPENEM 1 GRAM VIAL, manufactured by WG Critical Care, LLC, is $26.6295 per EA (NDC 44567082010), effective Sep 30, 2026.
How has the price of ERTAPENEM 1 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for ERTAPENEM 1 GRAM VIAL has declined 37.2%. It has been tracked across 172 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for ERTAPENEM 1 GRAM VIAL?
Since Jun 21, 2023, the NADAC for ERTAPENEM 1 GRAM VIAL has ranged from a low of $25.8742 (Jan 21, 2026) to a high of $46.9256 (Jul 10, 2024), with a median of $36.3239 per EA.
Are there cheaper alternatives to ERTAPENEM 1 GRAM VIAL?
No other NADAC-published product currently shares the active ingredient and strength of ERTAPENEM 1 GRAM VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ERTAPENEM 1 GRAM VIAL?
ERTAPENEM 1 GRAM VIAL (NDC 44567082010) is labeled by WG Critical Care, LLC, and CMS classifies it as a generic product.